RET-IN-15 is a rearranged during transfection (RET) kinase inhibitor extracted from patent WO2021115457A1 compound 51. RET-IN-15 can be used for the research of cancer[1].
Molecular Weight:
496.56
CAS Number:
[2643375-86-2]
Formula:
C27H28N8O2
Target:
RET
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted